Total revenue reflects all sources, including product sales of Nuvax. The company provided this information in a Form 8 filing.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVAX:
- Novavax (NASDAQ:NVAX) Stock Sinks on Stock Offering, U.K. Vaccine Deal
- Novavax announces $125M common stock offering
- Novavax call volume above normal and directionally bullish
- Novavax Nuvaxovid COVID-19 vaccine approved in Canada for ages 12-17
- Novavax’s COVID-19 vaccine issued Emergency Use update by WHO